As the Global Therapeutic Area Head of Neuroscience for Janssen Research & Development, Bill brings a diverse background in the biopharmaceutical industry and brain health scientific community. A scientist by training, his experience ranges from drug discovery and development, research portfolio planning, to licensing and partnerships.

In Bill's former role as Chief Scientific Officer and Head of R&D at BlackThorn Therapeutics, where he was a founding team member, he established the company’s scientific vision and helped grow the company from seed-stage through series-A funding. He began his industrial career at Merck where he contributed to the strategic direction of Merck’s Neuroscience franchise and chaired multiple CNS development teams, then continued into leadership positions at Theravance Biopharma. Bill is also a member of the President’s Advisory Council for Brown University’s Carney Institute for Brain Science and has held leadership positions in the Society for Neuroscience, the American Physiology Society and the International Brain Research Organization.